Clinical Trials
6 trialsNCT04721106 2026-02-10
Korea Post Marketing Surveillance (PMS) Study of Vizimpro
Pfizer
Completed
NCT04609319 2025-05-31
Real World Utilization and Outcomes With Dacomitinib First Line Treatment for EGFR Mutation-positive Advanced Non Small Cell Lung Cancer Among Asian Patients - A Multi Center Chart Review
Pfizer
Completed
NCT04155541 2025-05-23
Special Investigation for VIZIMPRO Tablets (Secondary Data Collection Study; Safety and Efficacy of VIZIMPRO Under Japanese Medical Practice)
Pfizer
Completed
NCT05834348 2025-03-30
DELINOR
Pfizer
Completed
NCT04768491 2021-02-24
Dacomitinib Treatment Followed by 3rd Generation EGFR-TKI in Patients With EGFR Mutation Positive Advanced NSCLC
Peking Union Medical College
Unknown
NCT04575415 2020-10-20
BELLA
Guangdong Association of Clinical Trials
Unknown